T1	Participants 123 153	high-risk haematology patients
T2	Participants 257 317	haematology patients at high risk of invasive aspergillosis.
T3	Participants 1801 1905	240 eligible patients were recruited from six Australian centres between Sept 30, 2005, and Nov 19, 2009
